1/2

FIEO Registered Export Ready

Auricord-Complementary Food Supplement Supports Cardiovascular Health

Name: Auricord-Complementary Food Supplement Supports Cardiovascular Health
Brand: aurinko
SKU: 8520879
Availability: InStoreOnly

Sold by aurinko healthcare pvt. ltd. · Manufacturer, Exporter · Faridabad, Haryana, India

Price

Price on request

In stock

Minimum order: 1 unit

Export Snapshot

MOQ

1 unit

Lead time

On request

Packaging

Standard export packaging

Shelf life / longevity

As per product specification

HS Code

9027

Origin

India

Port of dispatch

On request

Export markets served

Global markets

Values shown are for aurinko healthcare pvt. ltd..

Compliance & Certifications

FIEO Registered

Suitable for

Importers · Distributors · Wholesalers

Faridabad Dispatch on request FIEO member

aurinko healthcare pvt. ltd.

Manufacturer, Exporter · Faridabad, Haryana, India

Registered address: Faridabad, India.

View profile All products

Established

Not shared

Employees

–

GST

06AANCA0380R1Z7

IEC code

Not shared

Export markets

Global markets

GlobalLinker Member Since

Not shared

Turnover

Incorporation Type

On request

Verified Seller WHO-GMP HACCP ISO 9001:2015 (QMS)

Product details

What are the specifications of this product?

Overview

Auricord is a synergistic blend of Crataegus monogyna Nanophosphosome® and Crataegus monogyna, enhanced with advanced bioenhancer and metabolic potentiator technology to improve absorption, boost bioavailability, and prevent metabolic reduction for effective cardiovascular support and overall heart health.

Product Description

Auricord is a synergis c combina on of Crataegus monogyna Nanophosphosome®(Vitexin-2'-rhamnoside-Phospha dylcholine-Ethanolamine Inositol-Serine complex) and Crataegus monogyna with technologically advanced bioenhancer and metabolic poten ator technology. Bioenhancer and metabolic ac vator technology enhances the passive diffusion and ac ve transport mechanism through intes nal microvilli to improve absorp on as well prevents metabolic reduc on through inhibi on of P-gp efflux pump, ATPase ac vity, CYP3A4, CYP3AG and UGT.

Description provided by aurinko healthcare pvt. ltd..

Specifications

Patented Compound	Crataegus monogyna Nanophosphosome®
Active Flavonoid	Vitexin-2'-rhamnoside
Encapsulation Components	Phosphatidylcholine, Ethanolamine, Inositol, Serine
Metabolic Enzyme Inhibits	CYP3A4, CYP3A5, UGT, P-glycoprotein (P-gp)
Formulation Type	Herbal extract blend with nano-encapsulation technology
Delivery Mechanism	Enhanced intestinal absorption via bioenhancer and metabolic potentiator
Recommended Use	Cardiovascular dietary supplement ingredient
Dosage Form	Bulk powder or custom formulation compatible

Use cases

Category	Nutraceutical Ingredients > Herbal Extracts > Cardiovascular Support Extracts
Primary application	Wholesale, distribution, and international sourcing
Brand	aurinko
Product type	Product

Logistics & handling

Lead time	On request
Packaging	As per buyer requirement
Storage condition	As recommended by supplier
Origin	India
Form	As listed by supplier

Commercials (this seller)

Minimum order	1 unit
Lead time	On request
Payment terms	As per negotiated commercial agreement.
Checkout type	enquiry

Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing Auricord-Complementary Food Supplement Supports Cardiovascular Health. Answers compiled from verified sellers' commercial terms and platform data.

Q: How does Auricord improve cardiovascular health compared to traditional Crataegus monogyna extracts?

A: Auricord enhances cardiovascular benefits by using Nanophosphosome® technology combined with bioenhancers, which significantly increase the absorption and bioavailability of the active compounds, unlike traditional extracts that have poor systemic uptake.

Q: What metabolic pathways does Auricord inhibit to prevent degradation of active compounds?

A: Auricord inhibits key enzymes such as CYP3A4, CYP3A5, UDP-glucuronosyltransferase (UGT), and the P-glycoprotein efflux pump, which are responsible for metabolic reduction and efflux of active ingredients, thereby enhancing plasma concentration.

Q: Can Auricord be incorporated into existing supplement formulations without compromising stability?

A: Yes, Auricord’s nano-encapsulated format is designed for compatibility with various supplement formulations, ensuring stability and consistent delivery of active compounds without degradation during manufacturing.

Q: What specific compounds are encapsulated in the Nanophosphosome® complex of Auricord?

A: The Nanophosphosome® complex encapsulates Vitexin-2'-rhamnoside along with phosphatidylcholine, ethanolamine, inositol, and serine to enhance solubility, stability, and absorption.

Q: Is Auricord suitable for creating pharmaceutical-grade cardiovascular supplements?

A: Yes, Auricord provides a scientifically advanced extract designed with bioenhancer technology ideal for pharmaceutical, nutraceutical, and functional food applications targeting cardiovascular health.

Question not answered? Ask sellers directly — typical response within 4 hours.